slides · global inventory
11 Golden Circle
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 13,983
Current window 7,321-7,350
Pages 467
Rows per page 30
Loop
7,321-7,350 of 13,983
12
The slide serves as a section divider or introduction to the technology stack.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
13
Caribou Biosciences | IPO Presentation Deck | 44 slidesCaribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
14
The slide uses a process flow diagram to show the transition from raw materials to patient treatment.Caribou Biosciences | IPO Presentation Deck | 44 slides · Caribou Biosciences
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
04
Crocs | Investor Presentation Deck | 30 slidesCrocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
05
Crocs | Investor Presentation Deck | 30 slidesCrocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
06
Crocs | Investor Presentation Deck | 30 slidesCrocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
The slide uses a bulleted list to present key performance indicators, accompanied by a lifestyle image of the product.Crocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide uses a 2x2 grid layout to categorize sustainability initiatives.Crocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The pyramid uses product imagery as the background fill.Crocs | Investor Presentation Deck | 30 slides · Crocs
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
38
The slide uses a scientific mechanism of action diagram to illustrate the inhibition of the GEF binding region.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank Loop · Golden Circle1 hit
39
The table uses directional arrows (green up, yellow horizontal, orange down) to indicate performance relative to reference compounds.Erasca | IPO Presentation Deck | 46 slides · Erasca
Pitch deck Investment bank Loop · Golden Circle1 hit
05
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
The diagram uses a hub-and-spoke/triangular flow model to show how data flows between business units.LSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
07
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
LSE | Investor Day Presentation Deck | 100 slidesLSE | Investor Day Presentation Deck | 100 slides · LSEG
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
05
The slide uses a visual metaphor of orange slices as bullet points to reinforce the company brand.Orange County Bancorp | IPO Presentation Deck | 28 slides · Orange County Bancorp
Pitch deck Investment bank Loop · Golden Circle1 hit
06
The slide uses a process flow to explain the 'Learning' phase of their technology platform.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
07
The slide title is likely a continuation from a previous slide (e.g., '...to treat patients who are not eligible for standard therapies').TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
08
Uses a before-after-bridge style logic to illustrate the clinical advantage of multiplexing.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
09
The slide uses a Gantt-style visualization to show the current development stage of multiple drug candidates.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a color-coded legend to distinguish between liquid and solid tumor programs.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
11
TScan Therapeutics | IPO Presentation Deck | 43 slidesTScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
12
Uses a before-after-bridge framework to contrast current therapy limitations with TScan's solution.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
13
The slide uses a process flow diagram to explain a proprietary biotechnology platform.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
14
The slide uses a Venn diagram to explain the scope of their target discovery platform.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
15
The chart demonstrates the specificity of the TargetScan platform by highlighting MAGE-A3 as the primary target with significantly higher fold-enrichment.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
16
The chart displays fold-enrichment vs protein fragment number, identifying specific gene targets.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
17
The slide illustrates a dual-platform approach to TCR discovery and validation.TScan Therapeutics | IPO Presentation Deck | 43 slides · TScan Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit